David Hung

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Steven Robbins, as attorney in fact for Hung, David
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David Hung

Form 4 holding Director

NovoCure Ltd

Security class
Stock Option (Right to Buy)
Shares / value
16,999
Estimated value
$101,533
Report date
03 Jun 2026
Price
$16.30
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding PRESIDENT AND CEO, Director, 10%+ Owner

Nuvation Bio Inc.

Security class
Stock Option (Right to Buy)
Shares / value
1,995,012
Estimated value
Report date
27 Feb 2026
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

NovoCure Ltd

Security class
Restricted Stock Units
Shares / value
13,194
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct

Insider Reports Filed by David Hung

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .